Lilly Sues Teva To Block Generic Symbyax
By Marius Meland · April 27, 2005, 12:00 AM EDT
Eli Lilly and Co. has filed a lawsuit to bar Israeli drug maker Teva Pharmaceutical Industries Ltd. from marketing a generic version of the anti-psychotic drug Symbyax....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login